Positron emission tomography and breast lesions: Low FDG activity in early phase imaging is not essentially benign

Clinical Nuclear Medicine

Volumn 33, Issue 12, 2008, Pages 931-933

  Zytoon, Ashraf Anas ^a,b   Murakami, Koji ^b   El Kholy, Mohamed Ramdan ^a   Ebied, Osama ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; Delayed imaging; FDG PET CT; Standardized uptake value; SUV

Indexed keywords

FLUORODEOXYGLUCOSE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; BREAST CANCER; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; POSITRON EMISSION TOMOGRAPHY; BREAST TUMOR; PATHOLOGY; SCINTISCANNING;

AGED; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58749105154     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31818c4df6     Document Type: Article

References (10)

1. Buck A, Schirrmeister H, Kuhn T, et al. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging. 2002;29:1317-1323.
2. Nakamoto Y, Higashi T, Sakahara H, et al. Delayed 18F-fluoro-2-deoxy-D- glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer. 2000;89: 2547-2554.
3. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540-548.
4. Hustinx R, Smith RJ, Benard F, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med Mol Imaging. 1999;26:1345-1348.
5. Sahlmann CO, Siefker U, Lehmann K, et al. Dual time point 2-F-18 fluoro-2'-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis. Nucl Med Commun. 2004;25:819-823.
6. Yamada S, Kubota K, Kubota R, et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301-1306.
7. Matthies A, Hickeson M, Cuchiara A, et al. Dual time point F-18-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43: 871-875.
8. Xiu Y, Bhutani C, Dhurairaj T, et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med. 2007;32:101-105.
9. 18F-FDG-PET. J Nucl Med. 2005;46:1819-1824.
10. 18F-FDG-PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med. 2006;47:1440-1446.